Business Context and Reporting Period
This Form 8-K was filed by Dare Bioscience, Inc. on December 16, 2022. The company is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol "DARE".
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on a regulatory listing matter.
Material Changes and Events
On December 16, 2022, Dare Bioscience received a notice from the Nasdaq Listing Qualifications Department stating that the closing bid price of its common stock had been below the minimum $1.00 per share requirement for the last 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
Outlook, Risks, and Management Commentary
- Compliance Period: The company has been granted an initial 180-day compliance period, ending June 14, 2023, to regain compliance.
- Regaining Compliance: Compliance can be achieved if the closing bid price reaches at least $1.00 for a minimum of 10 consecutive business days during the initial period.
- Alternative Options: If the company fails to regain compliance by the deadline, it may be eligible for an additional 180-day period if it meets other listing standards and notifies Nasdaq of its intent to cure the deficiency, potentially through a reverse stock split.
- Risks: There is no assurance that the company will regain compliance or maintain other listing requirements. Failure to cure the deficiency could result in delisting, though the company retains the right to appeal such a determination.
Investor Verification Checklist
- Verify the current closing bid price of DARE stock to assess proximity to the $1.00 threshold.
- Monitor for any announcements regarding a reverse stock split or other capital structure changes intended to address the listing deficiency.
- Review the company's cash position and liquidity in subsequent filings (10-Q or 10-K) to evaluate its ability to fund operations while addressing the listing issue.
- Check for any updates on the status of the compliance period as the June 14, 2023, deadline approaches.